Clinical Trials Logo
  1. Home
  2. Pneumonitis
  3. NCT05455034

Single-cell Sequencing of BLF to Guide the Treatment of Radiation Pneumonitis or Immune Checkpoint Inhibitor Pneumonitis

Pneumonitis Clinical Trial

Official title:
Single-cell Sequencing of Bronchoalveolar Lavage Fluid to Guide the Treatment of Radiation Pneumonitis or Immune Checkpoint Inhibitor Pneumonitis

Clinical Trial Summary

A multicenter, exploratory clinical research, to map the radiation or immune checkpoint inhibitor pneumonitis in patients with alveolar lavage single-celled map. Find out the pathogenesis and prevention strategies of radiation or immune checkpoint inhibitor pneumonitis. Specific treatment is given based on the recommendation of the treatment guidelines for radiation or immune checkpoint inhibitor pneumonitis and the results of single cell sequencing, which will become a new technology for clinical application.

Clinical Trial Description

This study is a multicenter, exploratory clinical research, to map the radiation or immune checkpoint inhibitor pneumonitis in patients with alveolar lavage single-celled map. Find out the pathogenesis and prevention strategies of radiation or immune checkpoint inhibitor pneumonitis. Specific treatment is given based on the recommendation of the treatment guidelines for radiation or immune checkpoint inhibitor pneumonitis and the results of single cell sequencing, which will become a new technology for clinical application. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05455034
Study type Interventional
Source Xinqiao Hospital of Chongqing
Contact Jianguo Sun, doctor
Phone 023-68774490
Email sunjianguo@tmmu.edu.cn
Status Recruiting
Phase Phase 1/Phase 2
Start date August 1, 2023
Completion date June 30, 2025
View Details
See also
  Status Clinical Trial Phase
Completed NCT02246361 - Impact of Six Patient Information Leaflets (PIL) on Doctor Patient Communication Phase 4
Completed NCT00997555 - Prophylactic Bronchoscopy After Inhalation Injury in Burn Patients N/A
Recruiting NCT05280873 - Pirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of CIP Phase 1
Completed NCT00081315 - Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer Phase 2
Active, not recruiting NCT04590547 - GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19) Phase 2
Terminated NCT04370834 - Tocilizumab for Patients With Cancer and COVID-19 Disease Phase 2
Completed NCT02788643 - Study of Collagen IV and XIX in Bronchoalveolar Lavage, Pulmonary Aspiration and Bronchial Biopsies
Active, not recruiting NCT04326725 - Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia
Completed NCT03012958 - Utility of Lung Clearance Index Score as a Noninvasive Marker of Deployment Lung Disease
Completed NCT03730428 - Everolimus Related Pneumonitis in MBC
Completed NCT04721444 - Optimising Cancer Therapy And Identifying Causes of Pneumonitis USing Artificial Intelligence (COVID-19)
Terminated NCT04040244 - Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis N/A
Completed NCT04302688 - Accurate Classification System for Patients With COVID-19 Pneumonitis
Terminated NCT03962725 - Avoiding Neuromuscular Blockers to Reduce Complications Phase 4